» Authors » David Hackett

David Hackett

Explore the profile of David Hackett including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 484
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Niepsch D, Randviir E, Murphy-Peers R, Coulthard E, Hackett D, McKendry D, et al.
J Environ Manage . 2025 Mar; 380:124928. PMID: 40086284
By 2050, 90% of the Earth's topsoil is considered 'at risk' (according to the UN). Within the UK, more than 6 million hectares are at risk of compaction or erosion...
2.
Thinnes C, Waschkowitz R, Courtney E, Culligan E, Fahy K, Ferrazza R, et al.
bioRxiv . 2025 Feb; PMID: 39990405
The human microbiome plays a crucial role in metabolism and thereby influences health and disease. Constraint-based reconstruction and analysis (COBRA) has proven an attractive framework to generate mechanism-derived hypotheses along...
3.
Vickers S, Hackett D, Murray F, Hutson P, Heal D
J Psychopharmacol . 2015 Nov; 29(12):1290-307. PMID: 26589243
Binge-eating disorder is a common psychiatric disorder affecting ~2% of adults. Binge-eating was initiated in freely-fed, lean, adult, female rats by giving unpredictable, intermittent access to ground, milk chocolate over...
4.
Price C, Keene D, Hackett D
BMJ . 2014 Jan; 348:f7594. PMID: 24384520
No abstract available.
5.
Rowley H, Kulkarni R, Gosden J, Brammer R, Hackett D, Heal D
J Psychopharmacol . 2013 Dec; 28(3):254-69. PMID: 24327450
Lisdexamfetamine dimesylate is a novel prodrug approved in North America, Europe and Brazil for treating attention deficit hyperactivity disorder (ADHD). It undergoes rate-limited hydrolysis by red blood cells to yield...
6.
Heal D, Buckley N, Gosden J, Slater N, France C, Hackett D
Neuropharmacology . 2013 Jun; 73:348-58. PMID: 23748096
Lisdexamfetamine dimesylate, which consists of L-lysine covalently bound to D-amfetamine, is the first prodrug for treating ADHD. Its metabolic conversion to yield D-amfetamine by rate-limited, enzymatic hydrolysis is unusual because...
7.
Sen S, Asrress K, Nijjer S, Petraco R, Malik I, Foale R, et al.
J Am Coll Cardiol . 2013 Mar; 61(13):1409-20. PMID: 23500218
Objectives: This study sought to determine if adenosine administration is required for the pressure-only assessment of coronary stenoses. Background: The instantaneous wave-free ratio (iFR) is a vasodilator-free pressure-only measure of...
8.
Qureshi S, Hildick-Smith D, de Giovanni J, Clift P, Stuart G, Henderson R, et al.
Cardiol Young . 2012 May; 23(1):68-74. PMID: 22583564
In order to optimise care of the adult patients with complex congenital heart disease, there is a need to develop recommendations for interventions. This document is the work of representatives...
9.
Sen S, Escaned J, Malik I, Mikhail G, Foale R, Mila R, et al.
J Am Coll Cardiol . 2011 Dec; 59(15):1392-402. PMID: 22154731
Objectives: The purpose of this study was to develop an adenosine-independent, pressure-derived index of coronary stenosis severity. Background: Assessment of stenosis severity with fractional flow reserve (FFR) requires that coronary...
10.
Smith D, Toff W, Joy M, Dowdall N, Johnston R, Clark L, et al.
Heart . 2010 Jul; 96 Suppl 2:ii1-16. PMID: 20644218
No abstract available.